beta-sarcoglicanopathy.org

beta-sarcoglicanopathy.org

Give voice to beta-sarcoglycanopathy. Network of Friends Organization. Medical and scientific committee. MYONEXUS THERAPEUTICS SECURES $2.5 MILLION SEED. TO CLINICALLY ADVANCE LIMB-GIRDLE. MYO-101 Phase 1/2a systemic gene therapy trial for LGMD2E to begin in early 2018. The seed financing will enable Myonexus to initiate a systemic Phase 1/2a clinical trial of MYO-101. The company’s gene therapy candidate for treating LGMD2E (beta-sarcoglycanopathy), in early 2018. Myonexus’ pipeline also includes MY...

http://www.beta-sarcoglicanopathy.org/

OVERVIEW OF beta-sarcoglicanopathy.org

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

2

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR BETA-SARCOGLICANOPATHY.ORG

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.5 out of 5 with 4 reviews

5 star

1

4 star

2

3 star

0

2 star

0

1 star

1

Hey there! Start your review of beta-sarcoglicanopathy.org

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.6 seconds

FAVICON PREVIEW

16x16

CONTACTS AT BETA-SARCOGLICANOPATHY.ORG

Privacy Protection Service INC d/b/a PrivacyProtect.org

Domain Admin

C/O ID#1●●●●●●●●O Box 16

Nobb●●●●each , Queensland, QLD 4218

AU

45.3●●●●6676

co●●●●●@privacyprotect.org

View this contact

Privacy Protection Service INC d/b/a PrivacyProtect.org

Domain Admin

C/O ID#1●●●●●●●●O Box 16

Nobb●●●●each , Queensland, QLD 4218

AU

45.3●●●●6676

co●●●●●@privacyprotect.org

View this contact

Privacy Protection Service INC d/b/a PrivacyProtect.org

Domain Admin

C/O ID#1●●●●●●●●O Box 16

Nobb●●●●each , Queensland, QLD 4218

AU

45.3●●●●6676

co●●●●●@privacyprotect.org

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: n/a
UPDATED: 2013 November 08
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

NAME SERVERS

1: ns1.dominiofaidate.com
2: ns2.dominiofaidate.com

REGISTRAR

PDR Ltd. d/b/a PublicDomainRegistry.com (R27-LROR)

WHOIS : whois.publicinterestregistry.net

REFERRED :

CONTENT

PAGES IN
THIS WEBSITE

2

SSL

EXTERNAL LINKS

3

SITE IP

151.80.137.240

LOAD TIME

0.649 sec

SCORE

6.2

PAGE TITLE

beta-sarcoglicanopathy.org | beta-sarcoglicanopathy.org Reviews

<META> DESCRIPTION

Give voice to beta-sarcoglycanopathy. Network of Friends Organization. Medical and scientific committee. MYONEXUS THERAPEUTICS SECURES $2.5 MILLION SEED. TO CLINICALLY ADVANCE LIMB-GIRDLE. MYO-101 Phase 1/2a systemic gene therapy trial for LGMD2E to begin in early 2018. The seed financing will enable Myonexus to initiate a systemic Phase 1/2a clinical trial of MYO-101. The company’s gene therapy candidate for treating LGMD2E (beta-sarcoglycanopathy), in early 2018. Myonexus’ pipeline also includes MY...

<META> KEYWORDS

1 beta sarcoglicanopathy org

2 about us

3 what we do

4 contacts

5 newsletter

6 gfb meetings

7 support us

8 lgmd euronet

9 news flash

10 main menu

CONTENT

Page content here

KEYWORDS ON PAGE

beta sarcoglicanopathy org,about us,what we do,contacts,newsletter,gfb meetings,support us,lgmd euronet,news flash,main menu,the beta sarcoglycanopathy,research area,archive scientific pubblications,news,link,events and actions,italian telethon,username

SERVER

Apache/2.2.11 (Unix) DAV/2 mod_fastcgi/2.4.6 mod_ssl/2.2.22 OpenSSL/1.0.1t

POWERED BY

PHP/5.6.31

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

beta-sarcoglicanopathy.org | beta-sarcoglicanopathy.org Reviews

https://beta-sarcoglicanopathy.org

Give voice to beta-sarcoglycanopathy. Network of Friends Organization. Medical and scientific committee. MYONEXUS THERAPEUTICS SECURES $2.5 MILLION SEED. TO CLINICALLY ADVANCE LIMB-GIRDLE. MYO-101 Phase 1/2a systemic gene therapy trial for LGMD2E to begin in early 2018. The seed financing will enable Myonexus to initiate a systemic Phase 1/2a clinical trial of MYO-101. The company’s gene therapy candidate for treating LGMD2E (beta-sarcoglycanopathy), in early 2018. Myonexus’ pipeline also includes MY...

INTERNAL PAGES

beta-sarcoglicanopathy.org

1

beta-sarcoglicanopathy.org

http://www.beta-sarcoglicanopathy.org/index.php

Together we can win. Network of Friends Organization. Medical and scientific committee. DIRECT LINE GFB ONLUS-COLUMBUS,. In November 2015, the GFB ONLUS has started the first clinical trial for LGMD2E, with a contribution of $ 200,000. READ THE GENE THERAPY PROJECT AND THE UPDATES. Since 2012, the families of the GFB ONLUS have been funding without a ny other help. The preclinical gene therapy on. Limb Girdle Muscular Dystrophy. FROM WHEN AND HOW:. For a total of $ 1,100,000. Have been paid up today .

2

beta-sarcoglicanopathy.org

http://www.beta-sarcoglicanopathy.org/False

Give voice to beta-sarcoglycanopathy. Network of Friends Organization. Medical and scientific committee. DIRECT LINE GFB ONLUS-COLUMBUS,. In November 2015, the GFB ONLUS has started the first clinical trial for LGMD2E, with a contribution of $ 200,000. READ THE GENE THERAPY PROJECT AND THE UPDATES. Since 2012, the families of the GFB ONLUS have been funding without a ny other help. The preclinical gene therapy on. Limb Girdle Muscular Dystrophy. FROM WHEN AND HOW:. For a total of $ 1,100,000. During the ...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

2

LINKS TO THIS WEBSITE

cmdir.org

PatientCrossroads CMD

https://www.cmdir.org/index.php

Bio Bank and Tissue Repository. Registered affected individuals are required for:. Government intervention and funding. By registering you will also receive:. Notice of available clinical trials that apply to your registered profile. Notice of available therapies that apply to your registered profile when they become available. The Congenital Muscle Disease International Registry ( CMDIR. We will not be successful in finding a treatment or cure unless we know. Who the affected individuals are,. The follo...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

3

OTHER SITES

beta-s.pl

OŚRODEK MEDYCZNY LECZENIA BÓLU I MEDYCYNY NATURALNEJ

Tel (077) 442 52 30. Telkom. 0 601 466 975.

beta-s.skyrock.com

Blog de beta-S - βêta (s) - Skyrock.com

Mot de passe :. J'ai oublié mon mot de passe. Plus d'actions ▼. S'abonner à mon blog. Pour des raisons personnelles sur lesquelles je ne m'attarderai pas,. Le blog est en standby pour une durée de temps illimitée. En vous souhaitant, à tous, bonne continuation,. LES INSCRIPTIONS NE SE FONT QUE DANS LES SECTIONS CONCERNÉES. Valable également pour les demandes associations and autres . En espérant mieux vous servir,. Le staff βêta(s). Création : 22/11/2011 à 09:48. Mise à jour : 30/04/2012 à 09:10. Parce q...

beta-sa.com.ar

Beta S.A.

beta-sa.pl

BETA Systemy Alarmowe - Instalacje aramowe włamaniowe, telewizja przemysłowa, konstroli czasu pracy, kontroli dostępu, kontrola czasu pracy, kontrola dostępu, domofon, instalacje domofonowe, videofon, wideofon, instalacje videofonowe, sygnalizacja pożaru,

beta-sameday.dayrossgroup.com

Sameday Worldwide

ACI eManifest Requirements for Northbound Shipments. Click here to find out how much it costs before you ship. Day and Ross Recruiting Ad. Day and Ross Transportation Group.

beta-sarcoglicanopathy.org

Give voice to beta-sarcoglycanopathy. Network of Friends Organization. Medical and scientific committee. MYONEXUS THERAPEUTICS SECURES $2.5 MILLION SEED. TO CLINICALLY ADVANCE LIMB-GIRDLE. MYO-101 Phase 1/2a systemic gene therapy trial for LGMD2E to begin in early 2018. The seed financing will enable Myonexus to initiate a systemic Phase 1/2a clinical trial of MYO-101. The company’s gene therapy candidate for treating LGMD2E (beta-sarcoglycanopathy), in early 2018. Myonexus’ pipeline also includes MY...

beta-sarcoglicanopatie.it

Homepage

Dai voce alle beta-sarcoglicanopatie. IL GFB ONLUS HA I SUOI RAPPRESENTANTI NELLA MYONEXUS. LA COMPANY MYONEXUS THERAPEUTICS HA COSTITUITO LA COMMISSIONE SCIENTIFICA E QUELLA DEI PAZIENTI. Il GFB Onlus è ora presente nelle commissioni della Company Myonexus Therapeutics. CONCLUSA LA SECONDA CAMPAGNA SMS. CURIAMOLI 4.0" DEL GFB ONLUS. Il 17 febbraio si è conclusa la seconda campagna solidale Curiamoli 4.0. Il traguardo però non è ancora stato raggiunto e il GFB Onlus continua a impegnarsi per trovare altr...

beta-sarkoglykanopatie.de

Schliesse dich uns an. Zusammen kann man gewinnen. DIE GFB ONLUS TRÄUMT WIEDER. DIE DYSTROPHIE IST BALD GESCHLAGEN. Bis 2017 werden fünf neue Therapien fertig sein. Großes Aufatmen bei GFB onlus, die ein wichtiges Ziel in der wissenschaftlichen Forschung für die Kur der Raupenketten-Dystrophie erreicht hat, eine seltene Form von Muskeldystrophie, die in kurzer Zeit das Gehen und das Atmen behindert bis dann das Herz stillsteht. Zur Unterstützung vom Projekt nach Columbus überwiesen. Die GFB Onlus engagie...

beta-sauna.com

Index of /

Typo3 src lÃ /.

beta-scape.weebly.com

Beta-Scape - Home

Server Status : Offline atm. Client is needed to play! Http:/ www.mediafire.com/? Its just 19mb :). Kill the ultimate Bandos God :). Many updates soon you get here information about the update when it happen :). Create a free website.

beta-science.com

科学の進歩についていくため毎日がんばることを一覧にする

あまり堅苦しいものも良くありませんので、のしのタイプは外のしにして、表書きに御挨拶、のし下に自分の苗字を記名するように指定すれば良いでしょう。 Proudly powered by WordPress. Theme: Shoreditch by Automattic.